Omar S Aldibasi (Omar Aldibasi)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Systemic Lupus Erythematosus

Bariatric Surgery

Top Venues

Journal of the Endocrine Society

This page only lists publications with an associated author ORCID identifier.

Publications

Mamoon Rashid, Ali Al Qarni, Saeed Al Mahri, Sameer Mohammad, Altaf Khan, Mashan L Abdullah, Cynthia Lehe, Reem Al Amoudi, Omar S Aldibasi, Abderrezak Bouchama
Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes. Journal of the Endocrine Society 8 (1) (2023)
Mamoon Rashid, Ali Al Qarni, Saeed Al Mahri, Sameer Mohammad, Altaf Khan, Mashan L Abdullah, Cynthia Lehe, Reem Al Amoudi, Omar S Aldibasi, Abderrezak Bouchama
Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes. Journal of the Endocrine Society 8 (1) (2023)
Mamoon Rashid, Ali Al Qarni, Saeed Al Mahri, Sameer Mohammad, Altaf Khan, Mashan L Abdullah, Cynthia Lehe, Reem Al Amoudi, Omar S Aldibasi, Abderrezak Bouchama
Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes. Journal of the Endocrine Society 8 (1) (2023)
Kanan Alshammari, Faizah M Alotaibi, Futoon Alsugheir, Mohammad Aldawoud, Ashwaq Alolayan, Mohammed Ahmad Algarni, Fouad Sabatin, Mohammed F Mohammed, Abdulaziz Alosaimi, Faisal M Sanai, Hassan Odah, Ahmed Saleh Alshehri, Omar S Aldibasi, Samah Alrehaily, Abdullah S Al Saleh
Antibiotic Exposure Concurrently with Anti-PD1 Blockade Therapy Reduces Overall Survival in Patients with Child-Pugh Class A Advanced Hepatocellular Carcinoma. Cancers 16 (1) (2023)
Kanan Alshammari, Faizah M Alotaibi, Futoon Alsugheir, Mohammad Aldawoud, Ashwaq Alolayan, Mohammed Ahmad Algarni, Fouad Sabatin, Mohammed F Mohammed, Abdulaziz Alosaimi, Faisal M Sanai, Hassan Odah, Ahmed Saleh Alshehri, Omar S Aldibasi, Samah Alrehaily, Abdullah S Al Saleh
Antibiotic Exposure Concurrently with Anti-PD1 Blockade Therapy Reduces Overall Survival in Patients with Child-Pugh Class A Advanced Hepatocellular Carcinoma. Cancers 16 (1) (2023)